Vitreous: A barrier to nonviral ocular gene therapy

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 10, 2005, Pages 3553-3561

  Peeters, Liesbeth ^a   Sanders, Niek N ^a   Braeckmans, Kevin ^a   Boussery, Koen ^a   Van De Voorde, Johan ^a   De Smedt, Stefaan C ^a   Demeester, Joseph ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPOPLEX; LIPOSOME; MACROGOL; NANOPARTICLE; PLASMID DNA; POLYSTYRENE; SMALL INTERFERING RNA; DEXTRAN; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HYALURONIC ACID; MACROGOL DERIVATIVE; MICROSPHERE; POLYSTYRENE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BLEACHING; BLOOD BRAIN BARRIER; BLOOD EYE BARRIER; COMPLEX FORMATION; GEL ELECTROPHORESIS; GENE TARGETING; HYDROPHILICITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DISEASE; TARGET CELL; VITREOUS BODY; AGAR GEL ELECTROPHORESIS; ANIMAL; CATTLE; GENE THERAPY; GENE TRANSFER; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

ANIMALS; CATTLE; DEXTRANS; DNA; ELECTROPHORESIS, AGAR GEL; FLUORESCEIN-5-ISOTHIOCYANATE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HYALURONIC ACID; LIPID METABOLISM; MICROSPHERES; POLYETHYLENE GLYCOLS; POLYSTYRENES; VITREOUS BODY;

EID: 32944461193     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0165     Document Type: Article

References (39)

1. McLaughlin ME, Sandberg MA, Berson EL, Dryja TP. Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet. 1993; 4:130-134.
2. Farrar GJ, Kenna P, Jordan SA, et al. A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa. Nature. 1991;354:478-480.
3. Kajiwara K, Hahn LB, Mukai S, Travis GH, Berson EL, Dryja TP. Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature. 1991;354:480-483.
4. Delyfer MN, Leveillard T, Mohand-Said S, Hicks D, Picaud S, Sahel JA. Inherited retinal degenerations: therapeutic prospects. Biol Cell. 2004;96:261-269.
5. Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Drug delivery systems for vitreoretinal diseases. Prog Retinal Eye Res. 2004;23:253-281.
6. Weinreb RN. Enhancement of scierai macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc. 2001;99:319-343.
7. Duvvuri S, Majumdar S, Mitra AK. Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther. 2003;3:45-56.
8. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA. 1997;94:10319-10323.
9. Takahashi M, Miyoshi K, Verma IM, Gage FH, Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol. 1999;73:7812-7816.
10. Sarra GM, Stephens C, de-Alwis M, et al. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet. 2001;10:2353-2361.
11. Harvey AR, Kamphuis W, Eggers R, et al. Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors. Mol Cell Neurosci. 2002;21:141-157.
12. Sarra GM, Stephens C, Schlichtenbrede FC, et al. Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res. 1901;42:541-549.
13. Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci USA. 1999;96:9920-9925.
14. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
15. Sakamoto T, Ikeda Y, Yonemitsu Y. Gene targeting to the retina. Adv Drug Delivery Rev. 2001;52:93-102.
16. De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res. 2000;17:113-126.
17. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 1995;2:710-722.
18. Bishop, P. The biochemical structure of mammalian vitreous. Eye. 1996;10:664-670.
19. Scott JE. The chemical morphology of the vitreous. Eye. 1992;6: 553-555.
20. Ruponen M, Yla HS, Urtti A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim Biophys Acta Biomembr. 1999;1415:331-341.
21. Ruponen M, Honkakoski P, Ronkko S, Pelkonen J, Tammi M, Urtti A. Extracellular and intracellular barriers in non-viral gene delivery. J Control Release. 2003;93:213-217.
22. Ruponen M, Ronkko S, Honkakoski P, Pelkonen J, Tammi M, Urtti A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J Biol Chem. 2001;276:33875-33880.
23. Pitkanen L, Ruponen M, Nieminen J, Urtti A. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm Res. 2003;20:576-583.
24. Sanders NN, Van Rompaey E, De Smedt SC, Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am J Respir Crit Care Med. 2001;164:486-493.
25. Meyvis TKL, De-Smedt SC, Van-Oostveldt P, Demeester J. Fluorescence recovery after photobleacning: a versatile tool for mobility and interaction measurements in pharmaceutical research. Pharm Res. 1999;16:1153-1162.
26. Braeckmans K, Peeters L, Sanders NN, De Smedt SC, Demeester J. Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope. Biophys J. 2003;85: 2240-2252.
27. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;81:1930-1937.
28. Sanders NN, De-Smedt SC, Demeester J. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J Pharm Sci. 2000;89:835-849.
29. Saltzman WM, Radomsky ML, Whaley KJ, Cone RA. Antibody diffusion in human cervical mucus. Biophys J. 1994;66:508-515.
30. Szentkuti L. Light microscopical observations on luminally administered dyes, dextran, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J Control Rel. 1997;46:233-242.
31. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta. 1990;1029:91-97.
32. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta. 1991;1062:77-82.
33. Dunn SE, Brindley A, Davis SS, Davies MC, Ilium L. Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery, 2: the effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm Res. 1994;11:1016-1022.
34. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA. 1996;93:12349-12354.
35. Xu Y, Szoka F-CJ. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry. 1996;35:5616-5623.
36. Zelphati O, Szoka F-CJ. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA. 1996;93:11493-11498.
37. Xu J, Heys JJ, Barocas VH, Randolph TW. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm Res. 2000;17:664-669,
38. Stay MS, Xu J, Randolph TW, Barocas VH. Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor. Pharm Res. 2003;20:96-102.
39. Balazs EA, Denlinger JL. Aging and Human Visual Function. New York: AR Liss; 2005.